Biome Achieves Record Sales Revenue
Stock | Biome Australia Ltd (BIO.ASX) |
---|---|
Release Time | 1 Jul 2025, 8:44 a.m. |
Price Sensitive | Yes |
Biome Achieves Record Sales Revenue
- ~$18.4m annual sales revenue, up 41% vs PCP
- ~$5m Q4 sales revenue, up 33% vs PCP
- ~$2.1m June sales revenue, up 50% vs PCP
Biome Australia Limited (ASX: BIO) is pleased to announce unaudited full-year sales revenue of ~$18.4 million for FY25, representing 41% growth versus the previous corresponding period ($13.01m FY24). Biome recorded its strongest quarter to-date in Q4 FY25, with sales revenue exceeding $5 million, a 33% increase over the previous corresponding period (PCP Q4FY24: $3.78 million), supported by record monthly sales in June of ~$2.1 million, up 50% vs PCP. Entering FY26, Biome has achieved an annualised sales revenue run rate (ARR) of over $20 million, based on its Q4 performance. These results position Biome to meet its Vision 27 forecast of achieving at least $75 million in cumulative sales for FY25-27. Biome's domestic business sell-through, a key indicator of consumer demand, increased by over 50% in FY25, solidifying Biome's status as the category's leading growth brand. FY25 also saw significant international expansion, with the company securing new major retailers, wholesalers, and distributors across Canada, Ireland, United Kingdom and New Zealand. Biome anticipates reporting its sixth consecutive quarter of positive EBITDA for Q4 and its first full year of net profit in the FY25 accounts.
Biome anticipates reporting another quarter of positive EBITDA for Q4 and its inaugural full year of net profit in the FY25 accounts.
Biome is well on track to achieve its Vision 27 forecast of $75m+ in cumulative sales for FY25-27, supported by strong domestic growth and international expansion.